XbaI polymorphism of the estrogen receptor alpha gene influences the effect of raloxifene on the endothelial function

Maturitas

Volumn 67, Issue 1, 2010, Pages 84-90

  Zavratnik, Andrej ^a   Žegura, Branka ^a   Marc, Janja ^b   Preželj, Janez ^a   Pfeifer, Marija ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cell adhesion molecules; Endothelium dependent vasodilatation; ESR1 polymorphisms; Postmenopausal women; Raloxifene

Indexed keywords

CALCIUM CARBONATE; CELL ADHESION MOLECULE; COLECALCIFEROL; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTROGEN RECEPTOR ALPHA; RALOXIFENE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; ENDOTHELIUM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; TREATMENT DURATION; VASODILATATION;

AGED; E-SELECTIN; ENDOTHELIUM, VASCULAR; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MIDDLE AGED; OSTEOPOROSIS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; VASCULAR DISEASES; VASODILATION;

EID: 77955923043     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2010.05.011     Document Type: Article

References (47)

1. L. Mosca, J.E. Manson, S.E. Sutherland, R.D. Langer, T. Manolio, and E. Barrett-Connor Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing group Circulation 96 1997 2468 2482
2. P.D. Delmas, K.E. Ensrud, J.D. Adachi, K.D. Harper, S. Sarkar, and C. Gennari Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial J Clin Endocrinol Metab 87 2002 3609 3617
3. S. Cummings, S. Eckert, K. Krueger, D. Grady, T.J. Powles, and J.A. Cauley The effect of raloxifene on risk of breast cancer in postmenopausal women JAMA 281 1999 2189 2197
4. B.W. Walsh, L.H. Kuller, R.A. Wild, S. Paul, M. Farmer, and J.B. Lawrence Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women JAMA 279 1998 1445 1451
5. B.W. Walsh, S. Paul, R.A. Wild, R.A. Dean, R.P. Tracy, and D.A. Cox The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial J Clin Endocrinol Metab 85 2000 214 218
6. E. Barrett-Connor, D. Grady, A. Sashegyi, P.W. Anderson, D.A. Cox, and K. Hoszowski Raloxifene and cardiovascular events in osteoporotic postmenopausal woman: 4-year results from the MORE (multiple outcomes of raloxifene evaluation) randomised trial JAMA 287 2002 847 857
7. E. Barrett-Connor, L. Mosca, P. Collins, M.J. Geiger, D. Grady, and M. Kornitzer Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women N Engl J Med 355 2006 125 137
8. P. Collins, L. Mosca, M.J. Geiger, D. Grady, M. Kornitzer, and M.G. Amewou-Atisso Effects of The Selective Estrogen Receptor Modulator Raloxifene on Coronary Outcomes in The Raloxifene Use for the Heart Trial. Results of Subgroup Analyses by Age and Other Factors Circulation 119 2009 922 930
9. B. Erzen, M. Sabovic, M. Sebestjen, and P. Poredos Endothelial dysfunction, intima-media thickness, ankle-brachial pressure index, and pulse pressure in young post-myocardial infarction patients with various expressions of classical risk factors Heart Vessels 22 2007 215 222
10. T.A.M. Abdu, T. Elhad, M. Pfeifer, and R.N. Clayton Endothelial dysfunction in endocrine disease Trends Endocrinol Metab 12 2001 257 265
11. M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, and M.A. Creager Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
12. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
13. S.C. Schuit, H.H. Oei, J.C. Witteman, C.H. Geurts van Kessel, J.B. van Meurs, and R.L. Nijhuis Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction JAMA 291 2004 2969 2977
14. M. Alevizaki, K. Saltiki, A. Cimponeriu, I. Kanakakis, N. Xita, and C.C. Alevizaki Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor alpha polymorphic variants Eur J Endocrinol 156 2007 489 496
15. A. Yilmaz, S. Menevse, A.F. Erkan, M.A. Ergun, M.N. Ilhan, and A. Cengel The relationship of the ESR1 gene polymorphisms with the presence of coronary artery disease determined by coronary angiography Genet Test 11 2007 367 371
16. Y. Zhang, R. Xie, Y. Wang, D. Chen, G. Wang, and X. Xu Association of estrogen receptor gene polymorphism with cerebral infarction, a case-control study Zhonghua Yi Xue Za Zhi 82 2002 1443 1446
17. K. Hirschberg, T. Gombos, E. Dósa, A. Somorjai, A. Szilágyi, and G. Szabó Association between estrogen receptor alpha gene polymorphisms and early restenosis after eversion carotid endarterectomy and carotid stenting Atherosclerosis 206 2009 186 192
18. A. Molvarec, B. Nagy, M. Kovács, S. Walentin, E. Imreh, and J. Rigó Jr. Lipid, haemostatic and inflammatory variables in relation to the estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms Clin Chim Acta 380 2007 157 164
19. A. Molvarec, A. Vér, A. Fekete, K. Rosta, L. Derzbach, and Z. Derzsy Association between estrogen receptor alpha (ESR1) gene polymorphisms and severe preeclampsia Hypertens Res 30 2007 205 211
20. M. Boroumand, M. Ghaedi, N. Mohammadtaghvaei, L. Pourgholi, M.S. Anvari, and G. Davoodi Association of estrogen receptor alpha gene polymorphism with the presence of coronary artery disease documented by coronary angiography Clin Biochem 42 2009 835 839
21. A. Molvarec, G. Széplaki, M. Kovács, Z. Széplaki, A. Fazakas, and Z. Prohászka Estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms in ischemic stroke in a Hungarian population Clin Chim Acta 382 2007 100 105
22. M.J. Bos, S.C. Schuit, P.J. Koudstaal, A. Hofman, A.G. Uitterlinden, and M.M. Breteler Variation in the estrogen receptor alpha gene and risk of stroke: the Rotterdam Study Stroke 39 2008 1324 1326
23. D.M. Herrington, T.D. Howard, G.A. Hawkins, D.M. Reboussin, J. Xu, and S.L. Zheng Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease N Engl J Med 346 2002 967 974
24. D.M. Herrington, T.D. Howard, K.B. Brosnihan, D.P. McDonnell, X. Li, and G.A. Hawkins Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein Circulation 105 2002 1879 1882
25. A. Emre, S. Sahin, C. Erzik, Z. Nurkalem, D. Oz, and B. Cirakoglu Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease Cardiology 106 2006 44 50
26. A. Zavratnik, J. Prezelj, A. Kocijancic, and J. Marc Exonic, but not intronic polymorphisms of ESR1 gene might influence the hypolipemic effect of raloxifene J Steroid Biochem Mol Biol 104 2007 22 26
27. I.P. Heilberg, E. Hernandez, E. Alonzo, R. Valera, L.G. Ferreira, and S.A. Gomes Estrogen receptor (ER) gene polymorphism may predict the bone mineral density response to raloxifene in postmenopausal women on chronic hemodialysis Ren Fail 27 2005 155 161
28. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res 16 1998 1215
29. S. Kobayashi, S. Inoue, T. Hosoi, Y. Ouchi, M. Shiraki, and H. Orimo Association of bone mineral density with polymorphism of the estrogen receptor gene J Bone Miner Res 11 1996 306 311
30. S. Jurada, J. Marc, J. Preelj, A. Kocijani, and R. Komel Codon 325 sequence polymorphism of the estrogen receptor alpha gene and bone mineral density in postmenopausal women J Steroid Biochem Mol Biol 78 2001 15 20
31. D.S. Celermajer, K.E. Sorensen, D.J. Spiegelhalter, D. Georgakopoulos, J. Robinson, and J.E. Deanfield Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women J Am Coll Cardiol 24 1994 471 476
32. J.P. Ioannidis, S.H. Ralston, S.T. Bennett, M.L. Brandi, D. Grinberg, and F.B. Karassa GENOMOS Study. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes JAMA 292 2004 2105 2114
33. E. Ingelsson, A.C. Syvänen, and L. Lind Polymorphisms in the estrogen receptor alpha gene and endothelial function in resistance and conduit arteries in the elderly Atherosclerosis 199 2008 162 171
34. A.J. Jakimiuk, M. Bogusiewicz, P. Skorupski, A. Adamiak, P. Miotła, and J. Haczynski Relationship between estrogen receptor-alpha polymorphism and serum levels of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, C-reactive protein and homocysteine in postmenopausal women Gynecol Endocrinol 19 2007 1 6
35. T.P. Olson, K.H. Schmitz, A.S. Leon, and D.R. Dengel Vascular structure and function in women: relationship with body mass index Am J Prev Med 30 2006 487 492
36. K.M. Gavin, D.R. Seals, A.E. Silver, and K.L. Moreau Vascular endothelial estrogen receptor α is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women J Clin Endocrinol Metab 94 2009 3513 3520
37. E. Cerquetani, C. Vitale, G. Mercuro, M. Fini, S. Zoncu, and G.M. Rosano Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk Gynecol Endocrinol 18 2004 291 298
38. E.J. Duschek, C.D. Stehouwer, G.W. de Valk-de Roo, C.G. Schalkwijk, J. Lambert, and C. Netelenbos Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women J Intern Med 254 2003 85 94
39. G. Ceresini, L. Marchini, I. Rebecchi, S. Morganti, L. Bertone, and I. Montanari Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women Atherosclerosis 167 2003 121 127
40. A. Cagnacci, S. Arangino, A. Renzi, A.L. Zanni, and A. Volpe Raloxifene does not influence flow-mediated endothelium-dependent and endothelium- independent vasodilatation of osteopenic postmenopausal women Am J Obstet Gynecol 188 2003 313 317
41. K.A. Griffiths, M.A. Sader, M.R. Skilton, J.A. Harmer, and D.S. Celermajer Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease J Am Coll Cardiol 42 2003 698 704
42. A. Saitta, D. Altavilla, D. Cucinotta, N. Morabito, N. Frisina, and F. Corrado Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women Arterioscler Thromb Vasc Biol 21 2001 1512 1519
43. N. Colacurci, D. Manzella, F. Fornaro, M. Carbonella, and G. Paolisso Endothelial function and menopause: effects of raloxifene administration J Clin Endocrinol Metab 88 2003 2135 2140
44. P.M. Sarrel, H. Nawaz, W. Chan, M. Fuchs, and D.L. Katz Raloxifene and endothelial function in healthy postmenopausal women Am J Obstet Gynecol 188 2003 304 309
45. K. Takahashi, A. Mori-Abe, K. Takata, T. Ohta, J. Kawagoe, and S. Tsutsumi Raloxifene improves the ovariectomy-induced impairment in endothelium-dependent vasodilation Menopause 14 2007 656 661
46. E. Sbarouni, P. Flevari, C. Kroupis, Z.S. Kyriakides, K. Koniavitou, and D.T. Kremastinos The effects of raloxifene and simvastatin on plasma lipids and endothelium Cardiovasc Drugs Ther 17 2003 319 323
47. N. Colacurci, F. Fornaro, L. Cobellis, P. De Franciscis, M. Torella, and E. Sepe Raloxifene slows down the progression of intima-media thickness in postmenopausal women Menopause 14 2007 879 884